Nirmatrelvir plus ritonavir in patients with underlying rheumatological diseases, in preventing COVID-19 related hospitalization and death.

Authors :: Javed F
Mangino AA
Piranavan P
Source :: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Jul 03; Vol. 64 (1), pp. 50. Date of Electronic Publication: 2024 Jul 03.
Publication Year :: 2024

Subjects :: Humans
COVID-19 prevention & control
COVID-19 mortality
Male
SARS-CoV-2
Female
Middle Aged
Drug Therapy, Combination
Ritonavir therapeutic use
COVID-19 Drug Treatment
Hospitalization
Rheumatic Diseases drug therapy
Rheumatic Diseases complications

Full Text Access

Tools